Healthcare
Cyberdyne Inc.(CYBQY)
Live Price
Offline$1.40
-20.00% today
1Y Change
+42.86%
Window
Jun 27, 2025 โ Jun 18, 2026
- Market Cap
- $38.96B
- Revenue Growth
- +0.7%
- EPS Growth
- +60.9%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 27, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cyberdyne Inc. (CYBQY) is a Healthcare stock with a market cap of $38.96B and listed on OTC. The stock last traded around $1.40 and up 42.9% across the available one-year price window (Jun 27, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +0.7%, EPS growth of +60.9%, a dividend yield of 0.0%. What stands out right now is revenue +0.7%, EPS +60.9%, free cash flow +31.6% with operating margin -27.0% and ROIC -0.5%. Valuation already assumes a fairly strong business story at price/sales 9.5. Stock Foundry combines CYBQY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+0.7% vs +7.6% peer median
Operating Margin
Below sector median
-27.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +0.7% and EPS at +60.9%, with operating margin around -27.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -13.3% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | โ | +0.0% | -12.2% | +13.7% |
2026 Feb 11, 2026 | โ | +0.0% | +0.0% | -6.4% |
2025 Nov 12, 2025 | โ | +0.0% | -27.7% | -13.1% |
Benchmark Edge
CYBQY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CYBQY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CYBQY Max Drawdown
-40.87%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CYBQY and SPY.
Company Overview
Cyberdyne Inc.
OTC
Cyberdyne Inc. Sponsored ADR represents shares of Cyberdyne Inc., a Japanese company, in the United States financial markets. The primary function of this asset is to provide U.S. investors with access to Cyberdyne Inc.'s equity without the complexities of buying foreign stocks directly. Cyberdyne Inc. is known for pioneering innovations in the field of robotics and artificial intelligence, with a particular focus on developing assistive robotic devices for medical and public welfare applications, such as HAL (Hybrid Assistive Limb) exoskeletons. These technologies are significant in healthcare, elder care, and rehabilitation sectors, making substantial impacts on how robotic assistance can enhance human physical capabilities. By offering a Sponsored ADR, Cyberdyne enables a broader range of investors to participate in its growth story and technological advancements. The presence of Cyberdyne Inc. Sponsored ADR in the market underscores the increasing globalization of technology-driven companies and highlights investor interest in sectors like healthcare technology and robotics.
- Leadership
- Dr. Yoshiyuki Sankai
- Employees
- 211
- Street Address
- 2-2-1, Gakuen-Minami
- Mailing
- Tsukuba, 305-0818
- Region
- Tsukuba, Japan
- Last Updated
- May 10, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 9.5
- Price/Book
- 1.5
Growth
- Revenue
- +0.7%
- EPS
- +60.9%
- Free Cash Flow
- +31.6%
Profitability
- Gross Margin
- 49.9%
- Operating Margin
- -27.0%
- Net Margin
- -0.1%
- ROE
- -0.0%
- ROIC
- -0.5%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 14.87
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.